Document is current
Any future updates will be listed below
-
Authors
Sheehan, John Robert
Calpin, Padraig
Kernan, Maeve
Kelly, Claire
Casey, Siobhan
Murphy, Darragh
Alvarez-Iglesias, Alberto
Giacomini, Camilla
Cody, Catriona
Curley, Gerard
McGeary, Shane
Hanley, Ciara
McNicholas, Bairbre
van Haren, Frank
Laffey, John G.
Cosgrave, David https://orcid.org/0000-0002-5069-0201
-
Funding
Funding for this research was provided by:
Science Foundation Ireland (13/RC/2073)
- License Information
-
More Information
Article History
Received: 20 January 2022
Accepted: 6 July 2022
First Online: 14 September 2022
Declarations
:
: Written ethical approval was received from the COVID-19 National Research Ethics Committee (Ref No: 20-NREC-COV-104). Regulatory approval for the study was given by the Health Products Regulatory Authority (CT0900/650/001 Heparin Sodium). The patient consenting process for study participation was reviewed and approved by the Health Research Consent Declaration Committee (Ref: 20-026-AF1/COV). As detailed above, written informed consent/assent will be obtained from all participants.
: Written informed consent or assent was obtained from all patients prior to inclusion in the trial for collection, storage, analysis and dissemination of the results of the trial (attached).
: The authors declare that they have no competing interests.
